CRC-话题@MedSci

#CRC#

70篇内容 | 3670人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1827258, encodeId=f35d182e25885, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=PLK1抑制剂Onvasertib治疗KRAS突变的mCRC患者：肿瘤消退和临床获益, objectType=article, longId=186925, objectId=3f7618692587, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f7618692587, replyNumber=0, likeNumber=66, createdTime=2020-03-02, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f7618692587, moduleTitle=PLK1抑制剂Onvasertib治疗KRAS突变的mCRC患者：肿瘤消退和临床获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f7618692587)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827254, encodeId=80e3182e2543a, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=Gastroenterology：PDE5抑制剂有助于降低男性CRC风险, objectType=article, longId=167019, objectId=0cc216e019cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cc216e019cd, replyNumber=0, likeNumber=56, createdTime=2020-01-22, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cc216e019cd, moduleTitle=Gastroenterology：PDE5抑制剂有助于降低男性CRC风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cc216e019cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827255, encodeId=afb2182e25517, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=【2019 ASCO】化疗难治性mCRC患者瑞戈非尼治疗新进展, objectType=article, longId=167648, objectId=f57f16e64875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f57f16e64875, replyNumber=0, likeNumber=77, createdTime=2019-06-26, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f57f16e64875, moduleTitle=【2019 ASCO】化疗难治性mCRC患者瑞戈非尼治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f57f16e64875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827252, encodeId=0825182e252b0, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=王峰教授：PD-1单抗在结直肠癌（CRC）治疗中扮演更重要角色, objectType=article, longId=153981, objectId=3ce8153981d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ce8153981d4, replyNumber=0, likeNumber=81, createdTime=2019-07-05, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ce8153981d4, moduleTitle=王峰教授：PD-1单抗在结直肠癌（CRC）治疗中扮演更重要角色, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ce8153981d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827250, encodeId=b40e182e250e1, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=Ann Intern Med：结肠镜检查要重视！显著降低CRC死亡率，并改善预后, objectType=article, longId=132921, objectId=c98513292199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c98513292199, replyNumber=0, likeNumber=66, createdTime=2018-10-31, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c98513292199, moduleTitle=Ann Intern Med：结肠镜检查要重视！显著降低CRC死亡率，并改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c98513292199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827245, encodeId=b8bd182e2458c, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=寻求兼职CRC，待遇优厚, objectType=article, longId=119252, objectId=bb0d119252ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb0d119252ab, replyNumber=0, likeNumber=71, createdTime=2018-03-27, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb0d119252ab, moduleTitle=寻求兼职CRC，待遇优厚, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb0d119252ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827251, encodeId=5961182e25148, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=JCO：贝伐珠单抗治疗mCRC 18q11.2-q12.1缺失是福还是祸？, objectType=article, longId=146653, objectId=33e41466537f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33e41466537f, replyNumber=0, likeNumber=80, createdTime=2018-10-17, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33e41466537f, moduleTitle=JCO：贝伐珠单抗治疗mCRC 18q11.2-q12.1缺失是福还是祸？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33e41466537f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827246, encodeId=e5c2182e2466a, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=【我眼中的扬帆远航】总决赛冠军团队北肿CRC MDT·YOUNG团队专访, objectType=article, longId=121187, objectId=918f12118eb1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=918f12118eb1, replyNumber=0, likeNumber=47, createdTime=2018-07-25, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=918f12118eb1, moduleTitle=【我眼中的扬帆远航】总决赛冠军团队北肿CRC MDT·YOUNG团队专访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=918f12118eb1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827247, encodeId=4cb4182e2478a, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=Nat commun：在ccRCC中，HIF可通过脂肪酸代谢抑制促使脂质沉淀和癌变, objectType=article, longId=122967, objectId=24fb12296e85, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24fb12296e85, replyNumber=0, likeNumber=55, createdTime=2018-07-14, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24fb12296e85, moduleTitle=Nat commun：在ccRCC中，HIF可通过脂肪酸代谢抑制促使脂质沉淀和癌变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24fb12296e85)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827249, encodeId=4f1b182e24905, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=JAMA Surg：mCRC的靶向治疗：肿瘤原发部位和死亡率是否相关？, objectType=article, longId=131399, objectId=622d13139946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=622d13139946, replyNumber=0, likeNumber=101, createdTime=2018-04-14, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=622d13139946, moduleTitle=JAMA Surg：mCRC的靶向治疗：肿瘤原发部位和死亡率是否相关？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=622d13139946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827238, encodeId=bb0d182e23854, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=Ann Oncol：血浆ctDNA RAS基因突变分析用于mCRC患者诊断和治疗监测效果佳, objectType=article, longId=105262, objectId=a60610526214, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a60610526214, replyNumber=0, likeNumber=67, createdTime=2018-03-29, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a60610526214, moduleTitle=Ann Oncol：血浆ctDNA RAS基因突变分析用于mCRC患者诊断和治疗监测效果佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a60610526214)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827244, encodeId=1f4e182e2445b, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=J Clin OncoL:BRAF突变mCRC再细分，新突变亚型引人瞩目, objectType=article, longId=108813, objectId=a8b410881330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8b410881330, replyNumber=0, likeNumber=94, createdTime=2017-12-03, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8b410881330, moduleTitle=J Clin OncoL:BRAF突变mCRC再细分，新突变亚型引人瞩目, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8b410881330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827240, encodeId=3c2e182e24085, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=合理制定靶向药物使用顺序，使mCRC患者获益很大化, objectType=article, longId=106021, objectId=c9b710602185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9b710602185, replyNumber=0, likeNumber=73, createdTime=2017-08-23, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9b710602185, moduleTitle=合理制定靶向药物使用顺序，使mCRC患者获益很大化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9b710602185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827243, encodeId=481d182e2435d, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=ANNALS OF ONCOLOGY：液体活检RAS可指导mCRC一线抗EGFR治疗, objectType=article, longId=108462, objectId=42e5108462d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42e5108462d0, replyNumber=0, likeNumber=72, createdTime=2018-03-17, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42e5108462d0, moduleTitle=ANNALS OF ONCOLOGY：液体活检RAS可指导mCRC一线抗EGFR治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42e5108462d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827248, encodeId=c921182e24869, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=J Clin Oncol:CheckMate 142研究：dMMR/MSI-H 型mCRC的联合免疫治疗时代, objectType=article, longId=127483, objectId=749e12e48327, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=749e12e48327, replyNumber=0, likeNumber=71, createdTime=2018-07-21, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=749e12e48327, moduleTitle=J Clin Oncol:CheckMate 142研究：dMMR/MSI-H 型mCRC的联合免疫治疗时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=749e12e48327)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827242, encodeId=9c66182e2427b, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=ANN ONCOL:液体活检RAS可指导mCRC一线抗EGFR治疗, objectType=article, longId=108461, objectId=a9e21084618a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9e21084618a, replyNumber=0, likeNumber=61, createdTime=2018-03-14, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9e21084618a, moduleTitle=ANN ONCOL:液体活检RAS可指导mCRC一线抗EGFR治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9e21084618a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827241, encodeId=d709182e24146, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=【ASCO 2017】欧美权威专家访谈集锦：Her-2扩增检测为mCRC末线治疗方案提供线索, objectType=article, longId=106341, objectId=64261063415a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64261063415a, replyNumber=0, likeNumber=78, createdTime=2017-11-19, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64261063415a, moduleTitle=【ASCO 2017】欧美权威专家访谈集锦：Her-2扩增检测为mCRC末线治疗方案提供线索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64261063415a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827239, encodeId=7da3182e23904, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=Ann Oncol：血液和肿瘤组织的RAS突变检测方法用于指导mCRC抗EGFR治疗的一致性, objectType=article, longId=105800, objectId=603c10580098, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=603c10580098, replyNumber=0, likeNumber=67, createdTime=2018-03-29, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=603c10580098, moduleTitle=Ann Oncol：血液和肿瘤组织的RAS突变检测方法用于指导mCRC抗EGFR治疗的一致性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=603c10580098)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827237, encodeId=d89c182e237ea, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=护士作为临床协调员（CRC)的优势与行业发展, objectType=article, longId=98788, objectId=5b5098e8810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b5098e8810, replyNumber=0, likeNumber=52, createdTime=2017-12-11, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b5098e8810, moduleTitle=护士作为临床协调员（CRC)的优势与行业发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b5098e8810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1827236, encodeId=a12b182e23623, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, objectTitle=BJC：CpG岛甲基化表型与CRC预后无关, objectType=article, longId=82270, objectId=8cbf822e07a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cbf822e07a, replyNumber=0, likeNumber=78, createdTime=2017-01-15, rootId=0, userName=yxch36, userId=4cea26, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cbf822e07a, moduleTitle=BJC：CpG岛甲基化表型与CRC预后无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cbf822e07a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CRC

2020-05-29

yxch36 (审核中...)

前往app查看评论内容

#CRC#

PLK1抑制剂Onvasertib治疗KRAS突变的mCRC患者：肿瘤消退和临床获益

2020-03-02

yxch36 (审核中...)

前往app查看评论内容

#CRC#

Gastroenterology：PDE5抑制剂有助于降低男性CRC风险

2020-01-22

yxch36 (审核中...)

前往app查看评论内容

#CRC#

【2019 ASCO】化疗难治性mCRC患者瑞戈非尼治疗新进展

2019-06-26

yxch36 (审核中...)

前往app查看评论内容

#CRC#

王峰教授：PD-1单抗在结直肠癌（CRC）治疗中扮演更重要角色

2019-07-05

yxch36 (审核中...)

前往app查看评论内容

#CRC#

Ann Intern Med：结肠镜检查要重视！显著降低CRC死亡率，并改善预后

2018-10-31

yxch36 (审核中...)

前往app查看评论内容

#CRC#

寻求兼职CRC，待遇优厚

2018-03-27

yxch36 (审核中...)

前往app查看评论内容

#CRC#

JCO：贝伐珠单抗治疗mCRC 18q11.2-q12.1缺失是福还是祸？

2018-10-17

yxch36 (审核中...)

前往app查看评论内容

#CRC#

【我眼中的扬帆远航】总决赛冠军团队北肿CRC MDT·YOUNG团队专访

2018-07-25

yxch36 (审核中...)

前往app查看评论内容

#CRC#

Nat commun：在ccRCC中，HIF可通过脂肪酸代谢抑制促使脂质沉淀和癌变

2018-07-14

yxch36 (审核中...)

前往app查看评论内容

#CRC#

JAMA Surg：mCRC的靶向治疗：肿瘤原发部位和死亡率是否相关？

2018-04-14

yxch36 (审核中...)

前往app查看评论内容

#CRC#

Ann Oncol：血浆ctDNA RAS基因突变分析用于mCRC患者诊断和治疗监测效果佳

2018-03-29

yxch36 (审核中...)

前往app查看评论内容

#CRC#

J Clin OncoL:BRAF突变mCRC再细分，新突变亚型引人瞩目

2017-12-03

yxch36 (审核中...)

前往app查看评论内容

#CRC#

合理制定靶向药物使用顺序，使mCRC患者获益很大化

2017-08-23

yxch36 (审核中...)

前往app查看评论内容

#CRC#

ANNALS OF ONCOLOGY：液体活检RAS可指导mCRC一线抗EGFR治疗

2018-03-17

yxch36 (审核中...)

前往app查看评论内容

#CRC#

J Clin Oncol:CheckMate 142研究：dMMR/MSI-H 型mCRC的联合免疫治疗时代

2018-07-21

yxch36 (审核中...)

前往app查看评论内容

#CRC#

ANN ONCOL:液体活检RAS可指导mCRC一线抗EGFR治疗

2018-03-14

yxch36 (审核中...)

前往app查看评论内容

#CRC#

【ASCO 2017】欧美权威专家访谈集锦：Her-2扩增检测为mCRC末线治疗方案提供线索

2017-11-19

yxch36 (审核中...)

前往app查看评论内容

#CRC#

Ann Oncol：血液和肿瘤组织的RAS突变检测方法用于指导mCRC抗EGFR治疗的一致性

2018-03-29

yxch36 (审核中...)

前往app查看评论内容

#CRC#

护士作为临床协调员（CRC)的优势与行业发展

2017-12-11

yxch36 (审核中...)

前往app查看评论内容

#CRC#

BJC：CpG岛甲基化表型与CRC预后无关

2017-01-15

科室
- - 订阅+
  - 更多科室
工具
服务